Transcription repression and blocks in cell cycle progression in hypoplastic left heart syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Gambetta, Katheryn ^a   Al Ahdab, Mohamad K ^a   Ilbawi, Michel N ^a,b   Hassaniya, Nahidh ^c   Gupta, Madhu ^a,b  

^a ADVOCATE CHILDREN S HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Calcineurin; FoxP1; MYND domain containing transcription factor; Nuclear factor of activated T cells; Phosphatase and tensin homolog

Indexed keywords

CYCLIN DEPENDENT KINASE 4; HISTONE DEACETYLASE 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P18; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CYTOSKELETON PROTEIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHILD; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE REPRESSION; GENETIC TRANSCRIPTION; HEART ATRIUM SEPTUM; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; CASE CONTROL STUDY; CELL CYCLE; CLUSTER ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENETICS; HEART ATRIUM; METHODOLOGY; NEWBORN; PATHOLOGY; POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; CELL CYCLE; CELL CYCLE PROTEINS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLUSTER ANALYSIS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HEART ATRIA; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 44949184562     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91494.2007     Document Type: Article

References (45)

1. Andrés V, Chiara MD, Mahdavi V. A new bipartite DNA-binding domain: cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins. Genes Dev 2: 245-257, 1994.
2. Backs J, Olson E. Control of cardiac growth by histone acetylation/ deacetylation. Circ Res 98: 15-24, 2006.
3. Baek KH. Cytokine-regulated protein degradation by the ubiquitination system. Curr Protein Pept Sci 7: 171-177, 2006.
4. Bohlmeyer TB, Helmke S, Ge S, Lynch J, Brodsky G, Sederberg JH 2nd, Robertson AD, Minobe W, Bristow MR, Perryman MB. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype. Cardiovasc Pathol 12: 23-31, 2003.
5. Brady M, Koban MU, Dellow KA, Yacoub M, Boheler KR, Fuller SJ. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc Res 60: 347-354, 2003.
6. Chinnadurai G. CtBP family proteins: more than transcriptional corepressors. Bioessays 25: 9-12, 2003.
7. Cook AC. The phenotype during human fetal development. In: Hypoplastic Left Heart Syndrome, edited by Anderson R, Pozzi M, and Hutchinson S. London: Springer-Verlag, 2005, chapt. 2, p. 19-38.
8. Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res 91: 559-564, 2002.
9. Dang T, Bao S, Wang XF. Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability. Genes Cells 4: 287-295, 2005.
10. De La Pompa JL, Timmerman L, Takimoto H, Yoshida H, Elia A, Samper E, Potter J, Wakeham A, Marengere L, Langille B, Crabtree G, Mak T. Role of NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-185, 1998.
11. Fyler DC. Report of the New England Pediatric Cardiac Registry Program. Pediatrics 65: 375-461, 1980.
12. Gottlieb P, Pierce S, Sims R, Yamagishi H, Weihe E, Harriss J, Maika S, Kuziel W, King H, Olson E, Nakagawa O, Srivastava D. Bop encodes a muscle restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 31: 25-32, 2002.
13. Grossman K, Grund C, Huelsken J, Behrend M, Erdmann B, Franke W, Birchmeier W. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol 167: 149-160, 2004.
14. Gutgesell HP, Massaro TA. Management of hypoplastic left heart syndrome in a consortium of university hospitals. Am J Cardiol 76: 809-811, 1995.
15. Hildebrand JD, Soriano P. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol 22: 5296-5307, 2002.
16. Hinds PW. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation. Mol Cell 22: 432-433, 2006.
17. Hinton RB, Martin LJ, Tabangin ME, Mazwi ML, Cripe LH, Benson DW. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 50: 1590-1595, 2007.
18. Hofman TG, Moller A, Sirma H, Zentgraf Taya Y, Droge W, Will H, Schmitz ML. Regulation of p53 activity by its interaction with homeodomain interacting protein kinase-2. Nat Cell Biol 4: 11-19, 2002.
19. Iascone MR, Vittorini S, Collavoli A, Cupelli A, Kraft G, Biagini A, Clerico A. A rapid procedure for the quantitation of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects. J Endocrinol Invest 11: 835-842, 1999.
20. Kang MJ, Koh GY. Differential and dramatic changes of cyclin dependent kinases during cardiac development. J Mol Cell Cardiol 29: 1767-1777, 1997.
21. Lata J, Mooorthy NC, Murthy K, Manley J, Bustin M, Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12: 462-472, 1998.
22. Latif S, Masino A, Garry DJ. Transcriptional pathways direct cardiac development and regeneration. Trends Cardiovasc Med 16: 234-240, 2006.
23. Li J, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases, and cycline-dependent kinase inhibitors) and the cardiovascular system: potential targets for therapy? Eur Heart J 20: 406-420, 1999.
24. McGowan C, Russell P. Cell cycle regulation of human WEE1. EMBO J 14: 2166-2175, 1995.
25. Mohri K, Takano-Ohmuro H, Nakashima K, Hayakawa K, Endo T, Hanaoka K, Obinata T. Expression of cofilin isoforms during development of mouse striated muscles. J Muscle Res Cell Motil 21: 49-57, 2000.
26. Moncman C, Wang K. Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. Exp Cell Res 273: 204-218, 2002.
27. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292: 110-113, 2001.
28. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270: 1-15, 2001.
29. Olson E, Srivastava D. Molecular pathways controlling heart development. Science 272: 671-676, 1996.
30. Pasumarthi K, Field L. Cardiomyocyte cell cycle regulation. Circ Res 90: 1044-1054, 2002.
31. Plachon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 121: 249-253, 2008.
32. Ranger A, Grusby M, Hodge M, Gravallese E, de la Brousse F, Hoey T, Mickanin C, Baldwin H, Glimcher L. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186-190, 1998.
33. Salih C, McCarthy K, Yen S. The fibrous matrix of ventricular myocardium in hypoplastic left heart syndrome: a quantitative and qualitative analysis. Ann Thorac Surg 77: 36-40, 2004.
34. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85, 2004.
35. Sedmera D, Cook A, Shirali G, McQuinn TC. Current issues and perspectives in hypoplasia of the left heart. Cardiol Young 15: 56-72, 2005.
36. Sewalt R, Gunster M, van der Vlag J, Satijn D, Otte A. C-terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Cell Mol Biol 1: 777-787, 1999.
37. Shokeir MH. Hypoplastic left heart syndrome: an autosomal recessive disorder. Clin Genet 2: 7-14, 1971.
38. Soonpa MH, Kim KK, Pajak L, Franklin M, Field LJ. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol Heart Circ Physiol 271: H2183-H2189, 1996.
39. Tabibiazar R, Wagner RA, Liao A, Quertermous T. Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ Res 93: 1193-1201, 2003.
40. Tchernvenkov CI, Jacobs ML, Tahta S. Congenital heart surgery momenclature and database project: hypoplastic left heart syndrome. Ann Thorac Surg 69: S170-S179, 2000.
41. Thio S, Bonventre J, Hsu S. The CtBP2 corepressor is regulated by NADH-dependent dimerization and possess a novel N-terminal repressor domain. Nucleic Acids Res 32: 1836-1847, 2004.
42. Turner J, Crossley M. The CtBP family: enigmatic and enzymatic transcriptional co-repressors. Bioessays 23: 683-690, 2001.
43. Vernet C, Artzt K. STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13: 479-484, 1997.
44. Wang B, Weidenfeld J, Lu M, Maika S, Kuziel W, Morrisey E, Tucker P. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 131: 4477-4487, 2004.
45. Yang J. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell cycle arrest. Biochem Biophys Res Commun 297: 105-110, 2002.